U.S., Feb. 1 -- ClinicalTrials.gov registry received information related to the study (NCT06802822) titled 'Prevent Allosensitization in Patients Who Have Failed a First Renal Transplant (PART)' on Jan. 24.
Brief Summary: Kidney transplant is often the best treatment for people with kidney failure, but transplanted kidneys don't always last a lifetime. Many transplanted kidneys fail within 12 years, leaving patients needing dialysis or another transplant. One major issue is something called "allosensitization," which happens when the immune system attacks the donated kidney due to foreign markers on the kidney. This makes it harder to match a patient with another donor kidney in the future.
To try to prevent this, patients are given immun...